Holen Sie sich die Stockscreener-App
91.20
1.17%
-1.0418
Schlusskurs vom Vortag:
$92.24
Offen:
$92.1
24-Stunden-Volumen:
266.51K
Relative Volume:
0.53
Marktkapitalisierung:
$3.44B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-91.00M
KGV:
-24.85
EPS:
-3.67
Netto-Cashflow:
$-74.38M
1W Leistung:
+1.61%
1M Leistung:
+8.72%
6M Leistung:
+77.30%
1J Leistung:
+40.99%
1-Tages-Spanne:
$89.86
$92.89
1-Wochen-Bereich:
$87.18
$99.50
52-Wochen-Spanne:
$30.82
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Vergleichen Sie IRON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
91.20 | 3.48B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.54 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.82 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.91 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.83 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.92 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-03 | Fortgesetzt | Stifel | Buy |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-11 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
H.C. Wainwright reiterates Buy rating on Disc Medicine stock By Investing.com - Investing.com Canada
This is why Disc Medicine, Inc. (IRON) is a buy on Wall Street - MSN
This is Why Disc Medicine, Inc. (IRON) is a Buy on Wall Street - Finviz
Disc Medicine stock price target raised to $115 by Leerink on MF anemia data - Investing.com Canada
Disc Medicine (NASDAQ:IRON) Sets New 12-Month HighTime to Buy? - MarketBeat
ASH: Disc Set for Busy 2026 After Promising Interim Anemia Drug Data - Citeline News & Insights
Disc Medicine Inc stock hits 52-week high at 97.63 USD - Investing.com
Disc Medicine stock price target raised to $117 by Raymond James on trial data - Investing.com UK
Disc Medicine Advances Bitopertin in FDA Pilot Program - TipRanks
Disc Medicine, Inc. Reviews ASH Meeting Data and Operational Plans - TradingView
Disc Medicine (NASDAQ:IRON) Builds Momentum In Clinical Science - Kalkine Media
IRON Stock Boosted by Positive Phase 2 Trial Results of DISC-097 - GuruFocus
Transcript : Disc Medicine, Inc.Special Call - marketscreener.com
Bollard Group LLC Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine reveals encouraging Phase 2 data at ASH event - Traders Union
Disc Medicine reports positive data from DISC-0974 anemia trial - Investing.com
Disc Medicine Presents Positive Initial Data from RALLY-MF - GlobeNewswire
IRONAI Stock Analysis - Meyka
Saturn V Capital Management LP Sells 122,062 Shares of Disc Medicine, Inc. $IRON - MarketBeat
How Disc Medicine Inc. stock trades before earningsMarket Performance Summary & Consistent Growth Stock Picks - Newser
Disc Medicine Earnings Notes - Trefis
Certain Stock Options of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025. - marketscreener.com
Certain Pre-Funded Warrants of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025. - marketscreener.com
Disc Medicine, Inc. $IRON Shares Acquired by Sio Capital Management LLC - MarketBeat
Is Disc Medicine Inc. stock positioned well for digital economy2025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Disc Medicine (IRON) Stock Analysis Report | Financials & Insights - Benzinga
JPMorgan Chase & Co. Grows Position in Disc Medicine, Inc. $IRON - MarketBeat
Analysis Recap: How Disc Medicine Inc stock trades before earnings2025 EndofYear Setup & Free Verified High Yield Trade Plans - BỘ NỘI VỤ
Disc Medicine announces public offering of common stock and pre-funded warrants - MSN
Geode Capital Management LLC Purchases 26,605 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Behavioral Patterns of IRON and Institutional Flows - news.stocktradersdaily.com
DNB Asset Management AS Takes $243,000 Position in Disc Medicine, Inc. $IRON - MarketBeat
Is Disc Medicine Inc. stock attractive for hedge fundsRecession Risk & Expert Curated Trade Ideas - BỘ NỘI VỤ
Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock - AOL.com
Ensign Peak Advisors Inc Purchases 69,032 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Disc Medicine stock hits 52-week high at 96.09 USD By Investing.com - Investing.com Nigeria
Disc Medicine stock hits 52-week high at 96.09 USD - Investing.com
FY2025 EPS Estimate for Disc Medicine Decreased by Analyst - MarketBeat
Disc Medicine Inc. (IRON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How Disc Medicine Inc. stock performs in high volatility marketsGap Up & Free Fast Entry Momentum Trade Alerts - newser.com
Jefferies reiterates Buy rating on Disc Medicine stock ahead of key catalysts - Investing.com Canada
What technical charts say about Disc Medicine Inc. stockWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Is Disc Medicine Inc. stock attractive for passive investorsGap Up & Weekly High Conviction Ideas - newser.com
How sustainable is Disc Medicine Inc. stock dividend payout2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Disc Medicine Inc. stock momentum explainedPortfolio Return Summary & Fast Gaining Stock Strategy Reports - newser.com
Will Disc Medicine Inc. stock recover faster than marketTrade Volume Summary & Growth Focused Investment Plans - newser.com
What makes Disc Medicine Inc. stock attractive to growth fundsWatch List & Real-Time Volume Trigger Notifications - newser.com
Disc Medicine, Inc. $IRON Shares Sold by Patient Square Capital LP - MarketBeat
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
Disc Medicine Inc-Aktie (IRON) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Yu Jonathan Yen-Wen | Chief Operating Officer |
Nov 11 '25 |
Sale |
84.70 |
30,000 |
2,540,923 |
40,555 |
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):